USD 0.02
(-17.31%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.87 Million USD | -22.67% |
2022 | 6.09 Million USD | 106.95% |
2021 | 2.94 Million USD | -33.98% |
2020 | 4.46 Million USD | 12.14% |
2019 | 3.97 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.22 Million USD | 13.15% |
2024 Q2 | 1.07 Million USD | -7.99% |
2023 Q4 | 1.07 Million USD | -7.12% |
2023 FY | 4.71 Million USD | -22.67% |
2023 Q3 | 1.16 Million USD | -17.26% |
2023 Q2 | 1.4 Million USD | 18.05% |
2023 Q1 | 1.18 Million USD | -10.77% |
2022 Q2 | 2.36 Million USD | 208.58% |
2022 Q1 | 765.39 Thousand USD | -28.09% |
2022 FY | 6.09 Million USD | 106.95% |
2022 Q4 | 1.33 Million USD | -18.46% |
2022 Q3 | 1.63 Million USD | -30.8% |
2021 Q3 | 792.03 Thousand USD | 25.33% |
2021 Q4 | 1.06 Million USD | 34.38% |
2021 Q2 | 631.94 Thousand USD | 38.64% |
2021 Q1 | 455.8 Thousand USD | 1.84% |
2021 FY | 2.94 Million USD | -33.98% |
2020 Q3 | 2.33 Million USD | 177.96% |
2020 Q1 | 839.78 Thousand USD | 0.0% |
2020 FY | 4.46 Million USD | 12.14% |
2020 Q2 | 839.78 Thousand USD | 0.0% |
2020 Q4 | 447.58 Thousand USD | -80.83% |
2019 FY | 3.97 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Accolade, Inc. | 306.51 Million USD | 98.409% |
Aclarion, Inc. | 4.87 Million USD | 0.0% |
Augmedix, Inc. | 40.3 Million USD | 87.903% |
HeartBeam, Inc. | 15.31 Million USD | 68.162% |
HeartBeam, Inc. | 15.31 Million USD | 68.162% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | 10.165% |
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 99.621% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 99.621% |
CareCloud, Inc. | 93.35 Million USD | 94.777% |
CareCloud, Inc. | 93.35 Million USD | 94.777% |
Certara, Inc. | 254.08 Million USD | 98.081% |
CareMax, Inc. | 670.05 Million USD | 99.272% |
Definitive Healthcare Corp. | 546.47 Million USD | 99.108% |
EUDA Health Holdings Limited | 4.8 Million USD | -1.51% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.911% |
Health Catalyst, Inc. | 258.73 Million USD | 98.116% |
Healthcare Triangle, Inc. | 18.12 Million USD | 73.1% |
MSP Recovery, Inc. | 565.43 Million USD | 99.138% |
Mangoceuticals, Inc. | 9.65 Million USD | 49.477% |
National Research Corporation | 52.52 Million USD | 90.717% |
Nutex Health, Inc. | 66.54 Million USD | 92.673% |
OptimizeRx Corporation | 69.3 Million USD | 92.965% |
R1 RCM Inc. | 336.6 Million USD | 98.551% |
Renalytix Plc | 29.04 Million USD | 83.211% |
Sharecare, Inc. | 225.97 Million USD | 97.842% |
Sharecare, Inc. | 225.97 Million USD | 97.842% |
SHL Telemedicine Ltd. | 34.26 Million USD | 85.772% |
Spok Holdings, Inc. | 90.97 Million USD | 94.641% |
Streamline Health Solutions, Inc. | 31.19 Million USD | 84.368% |
TruBridge, Inc. | 206.17 Million USD | 97.635% |
10x Genomics, Inc. | 674.94 Million USD | 99.278% |
Zhongchao Inc. | 13.92 Million USD | 64.98% |